Merck (MRK) Intangibles (2009 - 2026)
Merck (MRK) reported Intangibles of $24.98 billion for Q2 2026, up 64.4% from $15.19 billion a year earlier but down 3.0% from the prior quarter.
Powered by 
Analysis
Merck (MRK) Intangibles (2009 - 2026) Analysis & Trends
At the end of FY2025, Merck posted Intangibles of $26.68 billion, up 63.0% from FY2024.
- Intangibles has a five-year compound annual growth rate of 13.6% (FY2020 to FY2025).
- By year, Intangibles came in at $16.37 billion in FY2024 (-9.1%), $18.01 billion in FY2023 (-11.1%), $20.27 billion in FY2022 (-11.6%) and $22.93 billion in FY2021 (+62.6%).
- Five-year quarterly Intangibles spans a low of $13.38 billion in Q3 2021 and a high of $26.68 billion in Q4 2025.
- Year over year, Intangibles has now increased in each of the last three quarters, with growth averaging 17.4% over the last eight quarters.
- The high point for year-over-year Intangibles in five years was Q2 2022 (growth of 65.2%); the low point was Q3 2021 (a decline of 19.7%).
- Per Business Quant data, the three quarters before Q2 2026 came in at $25.75 billion (Q1 2026), $26.68 billion (Q4 2025) and $15.31 billion (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 18.08 Bn |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 46.65 Bn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | 56.65 Bn |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 24.48 Bn |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | 11.80 Bn |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | 38.15 Bn |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 19.54 Bn |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | 13.42 Bn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 45.96 Bn |
| 10 | Vertex Pharmaceuticals | 138.90 Bn | 106.64 Bn | 2.91 Bn | 8.52 Bn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 24.48 Bn |
| Jun 30, 2026 | 24.98 Bn |
| Mar 31, 2026 | 25.75 Bn |
| Dec 31, 2025 | 26.68 Bn |
| Sep 30, 2025 | 15.31 Bn |
| Jun 30, 2025 | 15.19 Bn |
| Mar 31, 2025 | 15.76 Bn |
| Dec 31, 2024 | 16.37 Bn |
| Sep 30, 2024 | 17.01 Bn |
| Jun 30, 2024 | 16.98 Bn |
| Mar 31, 2024 | 17.57 Bn |
| Dec 31, 2023 | 18.01 Bn |
| Sep 30, 2023 | 19.20 Bn |
| Jun 30, 2023 | 19.67 Bn |
| Mar 31, 2023 | 19.86 Bn |
| Dec 31, 2022 | 20.27 Bn |
| Sep 30, 2022 | 21.37 Bn |
| Jun 30, 2022 | 22.50 Bn |
| Mar 31, 2022 | 23.02 Bn |
| Dec 31, 2021 | 22.93 Bn |
API Access
Merck Intangibles API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=intangibles&ticker=MRK&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "intangibles", "ticker": "MRK", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=intangibles&ticker=MRK&period=max&api_key=YOUR_API_KEY");
const data = await res.json();